Published in J Thorac Cardiovasc Surg on October 01, 2001
Endoventricular patch plasty for dyskinetic anteroapical left ventricular aneurysm increases systolic circumferential shortening in sheep. J Thorac Cardiovasc Surg (2007) 1.88
Dor procedure for dyskinetic anteroapical myocardial infarction fails to improve contractility in the border zone. J Thorac Cardiovasc Surg (2010) 1.25
Left ventricular volume and function after endoventricular patch plasty for dyskinetic anteroapical left ventricular aneurysm in sheep. J Thorac Cardiovasc Surg (2005) 1.05
Surgical ventricular restoration to reverse left ventricular remodeling. Curr Cardiol Rev (2010) 1.03
Characterizing heart failure in the ventricular volume domain. Clin Med Insights Cardiol (2015) 0.81
The Effects of Levosimendan and Sodium Nitroprusside Combination on Left Ventricular Functions After Surgical Ventricular Reconstruction in Coronary Artery Bypass Grafting Patients. Open Cardiovasc Med J (2016) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell (2000) 10.25
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation (1997) 4.54
Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol (1983) 2.91
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg (1997) 2.01
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
A regional survey of health insurance coverage for complementary and alternative medicine: current status and future ramifications. J Altern Complement Med (2001) 1.77
Ventricular efficiency predicted by an analytical model. Am J Physiol (1986) 1.70
Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg (2001) 1.68
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg (1998) 1.63
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
In vitro validation of a new cardiac catheter technique for recording monophasic action potentials. Eur Heart J (1986) 1.56
Hemodynamic consequences of ventricular interaction as assessed by model analysis. Am J Physiol (1991) 1.51
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation (1986) 1.47
Preservation of anterior leaflet chordae tendineae during mitral valve replacement. Ann Thorac Surg (1994) 1.47
Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg (1997) 1.47
Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg (1995) 1.42
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med (2000) 1.40
Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg (1994) 1.40
Assessment of transmyocardial perfusion in alligator hearts. Circulation (1997) 1.39
Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg (1998) 1.39
Discrepancy between claimed field flux density of some commercially available magnets and actual gaussmeter measurements. Altern Ther Health Med (2001) 1.39
Influence of pacing site on canine left ventricular contraction. Am J Physiol (1986) 1.33
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation (2000) 1.32
Surgical management of the patient with an implanted cardiac device: implications of electromagnetic interference. Ann Surg (1999) 1.28
Experience with heart transplantation for cardiac tumors. J Heart Lung Transplant (1995) 1.28
Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med (1997) 1.24
beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation (2001) 1.23
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet (2000) 1.22
Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation (2000) 1.21
Novel technique to repair type A acute aortic dissection in patients with a left ventricular assist device. Ann Thorac Surg (2001) 1.21
Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res (1989) 1.20
Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol (1993) 1.20
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation (1997) 1.20
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg (1999) 1.16
Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. J Heart Lung Transplant (1996) 1.14
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation (1996) 1.12
Changes in type I collagen following laser welding. Lasers Surg Med (1992) 1.12
Postextrasystolic potentiation of the isolated canine left ventricle. Relationship to mechanical restitution. Circ Res (1985) 1.12
A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg (2000) 1.11
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest (1994) 1.10
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Hepatobiliary complications of polyarteritis nodosa. Arch Surg (1991) 1.09
Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci U S A (1997) 1.08
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg (2000) 1.08
Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability. J Clin Invest (1985) 1.06
Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol (2001) 1.06
Contractility-dependent curvilinearity of end-systolic pressure-volume relations. Am J Physiol (1987) 1.05
Accuracy of volume measurement by conductance catheter in isolated, ejecting canine hearts. Circulation (1985) 1.04
Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2000) 1.04
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann Thorac Surg (1999) 1.01
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation (1999) 1.01
Nonlinearity and load sensitivity of end-systolic pressure-volume relation of canine left ventricle in vivo. Circulation (1991) 1.01
Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01
Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant (1999) 1.00
The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A (1994) 0.99
Evolution and resolution of long-term cardiac memory. Circulation (1998) 0.99
Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation (2001) 0.98
Radical excisional therapy and total cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg (1995) 0.97
Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol (1997) 0.96
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95
Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg (1999) 0.95
Effects of afterload on regional left ventricular torsion. Cardiovasc Res (1996) 0.95
Transaortic repair of mitral regurgitation. Heart Surg Forum (2000) 0.94
Fungal left ventricular assist device endocarditis. Ann Thorac Surg (2001) 0.94
Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg (1998) 0.94
Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res (1995) 0.94
Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant (1998) 0.94
A role for the renin-angiotensin system in the evolution of cardiac memory. J Cardiovasc Electrophysiol (1999) 0.94
Histologic analysis of transmyocardial channels: comparison of CO2 and holmium:YAG lasers. Ann Thorac Surg (1997) 0.94
Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc Surg (1999) 0.93
Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg (1996) 0.93
Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann Thorac Surg (2000) 0.93
Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg (1996) 0.93
The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology (1995) 0.93
Mechanical restitution of isolated perfused canine left ventricles. Am J Physiol (1984) 0.93
Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation (2001) 0.92
Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg (2000) 0.92
Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure. Circ Res (1992) 0.91
Normalized diastolic properties after left ventricular assist result from reverse remodeling of chamber geometry. Circulation (2001) 0.91